You just read:

Osteros Biomedica Presents Results of a Phase 1 Study of MBC-11, a Bone-Targeting Conjugate in Cancer Patients with Bone Metastases at ASCO Annual Meeting 2017

News provided by

Osteros Biomedica

Jun 01, 2017, 09:00 ET